Cargando…

Developments in the formulation and delivery of spray dried vaccines

Spray drying is a promising method for the stabilization of vaccines, which are usually formulated as liquids. Usually, vaccine stability is improved by spray drying in the presence of a range of excipients. Unlike freeze drying, there is no freezing step involved, thus the damage related to this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanojia, Gaurav, Have, Rimko ten, Soema, Peter C., Frijlink, Henderik, Amorij, Jean-Pierre, Kersten, Gideon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647985/
https://www.ncbi.nlm.nih.gov/pubmed/28925794
http://dx.doi.org/10.1080/21645515.2017.1356952
_version_ 1783272322785869824
author Kanojia, Gaurav
Have, Rimko ten
Soema, Peter C.
Frijlink, Henderik
Amorij, Jean-Pierre
Kersten, Gideon
author_facet Kanojia, Gaurav
Have, Rimko ten
Soema, Peter C.
Frijlink, Henderik
Amorij, Jean-Pierre
Kersten, Gideon
author_sort Kanojia, Gaurav
collection PubMed
description Spray drying is a promising method for the stabilization of vaccines, which are usually formulated as liquids. Usually, vaccine stability is improved by spray drying in the presence of a range of excipients. Unlike freeze drying, there is no freezing step involved, thus the damage related to this step is avoided. The edge of spray drying resides in its ability for particles to be engineered to desired requirements, which can be used in various vaccine delivery methods and routes. Although several spray dried vaccines have shown encouraging preclinical results, the number of vaccines that have been tested in clinical trials is limited, indicating a relatively new area of vaccine stabilization and delivery. This article reviews the current status of spray dried vaccine formulations and delivery methods. In particular it discusses the impact of process stresses on vaccine integrity, the application of excipients in spray drying of vaccines, process and formulation optimization strategies based on Design of Experiment approaches as well as opportunities for future application of spray dried vaccine powders for vaccine delivery.
format Online
Article
Text
id pubmed-5647985
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-56479852017-11-01 Developments in the formulation and delivery of spray dried vaccines Kanojia, Gaurav Have, Rimko ten Soema, Peter C. Frijlink, Henderik Amorij, Jean-Pierre Kersten, Gideon Hum Vaccin Immunother Review Spray drying is a promising method for the stabilization of vaccines, which are usually formulated as liquids. Usually, vaccine stability is improved by spray drying in the presence of a range of excipients. Unlike freeze drying, there is no freezing step involved, thus the damage related to this step is avoided. The edge of spray drying resides in its ability for particles to be engineered to desired requirements, which can be used in various vaccine delivery methods and routes. Although several spray dried vaccines have shown encouraging preclinical results, the number of vaccines that have been tested in clinical trials is limited, indicating a relatively new area of vaccine stabilization and delivery. This article reviews the current status of spray dried vaccine formulations and delivery methods. In particular it discusses the impact of process stresses on vaccine integrity, the application of excipients in spray drying of vaccines, process and formulation optimization strategies based on Design of Experiment approaches as well as opportunities for future application of spray dried vaccine powders for vaccine delivery. Taylor & Francis 2017-09-19 /pmc/articles/PMC5647985/ /pubmed/28925794 http://dx.doi.org/10.1080/21645515.2017.1356952 Text en © 2017 The Author(s). Published with license by Taylor & Francis http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Review
Kanojia, Gaurav
Have, Rimko ten
Soema, Peter C.
Frijlink, Henderik
Amorij, Jean-Pierre
Kersten, Gideon
Developments in the formulation and delivery of spray dried vaccines
title Developments in the formulation and delivery of spray dried vaccines
title_full Developments in the formulation and delivery of spray dried vaccines
title_fullStr Developments in the formulation and delivery of spray dried vaccines
title_full_unstemmed Developments in the formulation and delivery of spray dried vaccines
title_short Developments in the formulation and delivery of spray dried vaccines
title_sort developments in the formulation and delivery of spray dried vaccines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647985/
https://www.ncbi.nlm.nih.gov/pubmed/28925794
http://dx.doi.org/10.1080/21645515.2017.1356952
work_keys_str_mv AT kanojiagaurav developmentsintheformulationanddeliveryofspraydriedvaccines
AT haverimkoten developmentsintheformulationanddeliveryofspraydriedvaccines
AT soemapeterc developmentsintheformulationanddeliveryofspraydriedvaccines
AT frijlinkhenderik developmentsintheformulationanddeliveryofspraydriedvaccines
AT amorijjeanpierre developmentsintheformulationanddeliveryofspraydriedvaccines
AT kerstengideon developmentsintheformulationanddeliveryofspraydriedvaccines